Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Centre Francois Baclesse
Age
18–any
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
For patients
Women with breast cancer and / or ovarian cancer meet criteria suggestive of a hereditary predisposition
Deleterious mutation of BRCA1 and BRCA2 sought and not highlighted
Age ≥ 18 years
Agreeing to participate in the study (a collection of signed informed consent)
For control population
Women with no history of breast and / or ovarian cancer and no family history of breast and / or ovarian cancer among family members on the 1st and 2nd degree before age 50 for breast cancer and before 60 years for ovarian cancer
Agreeing to participate in the study (a collection of signed informed consent)
You may not be if
For patients:
Patients with a known deleterious mutation in BRCA1 and BRCA2
Patients do not meet criteria suggestive of a hereditary predisposition
Persons deprived of liberty or under guardianship (including guardianship)
For control population:
Males
Personal or family history of breast and / or ovarian cancer (breast or ovarian cancer in their family experienced 1st and 2nd degree before age 50 for breast cancer before age 60 for cancer ovarian)
Persons deprived of liberty or under guardianship (including guardianship)
